RASTETTER WILLIAM H

Director at ILLUMINA, INC. · on record since Jun 9, 2006
Director at NEUROCRINE BIOSCIENCES INC · on record since Feb 8, 2010
Director at FATE THERAPEUTICS INC · on record since May 6, 2026
Director at Receptos, Inc. · on record since May 14, 2013
Director at Regulus Therapeutics Inc. · on record since Jun 10, 2013
Director at BIOGEN INC. · on record since Feb 10, 2004
Executive Chairman at BIOGEN INC. · on record since Feb 10, 2004
Director at Dare Bioscience, Inc. · on record since Apr 17, 2014

Insider trading activity of RASTETTER WILLIAM H

Transactions on record: 275; since Feb 10, 2004

Open-market buys: 10; $8M

Open-market sells: 50; $55.3M

Companies traded: 7; last filing Jul 2, 2026

Figures computed from official regulatory filings — .

Companies where RASTETTER WILLIAM H has traded

Dare Bioscience, Inc.34 tx · $169.6K · Jul 2, 2026
FATE THERAPEUTICS INC21 tx · $1.5M · Jun 15, 2026
NEUROCRINE BIOSCIENCES INC49 tx · $17M · May 29, 2026
Regulus Therapeutics Inc.49 tx · $2M · Jun 27, 2025
ILLUMINA, INC.73 tx · $10M · Jan 4, 2016
Receptos, Inc.21 tx · $43.4M · Aug 27, 2015
BIOGEN INC.28 tx · $12.1M · Jul 1, 2005

Track record of RASTETTER WILLIAM H

Statistical track record

Free account

Open-market buys: 11

Last buy: May 7, 2019

Win rates, median returns and the proven-insider analysis come with a free account.

Transaction history of RASTETTER WILLIAM H

Co-insiders of RASTETTER WILLIAM H

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Dare Bioscience, Inc.Listing on record	Jul 2, 2026	Award	38,862	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Jun 15, 2026	AwardD (derivative)	87,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Jun 11, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 29, 2026	AwardD (derivative)	2,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	ExerciseD (derivative)	-3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	Exercise	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	May 6, 2026	ExerciseD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	May 6, 2026	Exercise	25,000	1.69 USD	$42.3K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	ExerciseD (derivative)	-18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	Exercise	18,000	47.89 USD	$862K	Unusual size	SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	Sell	-18,000	151.82 USD	$2.7M	Unusual size	SEC
Dare Bioscience, Inc.Listing on record	Jul 10, 2025	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-44,264	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-57,292	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	Exercise	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	ExerciseD (derivative)	-2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC

Company	Filed	Type	Qty	Price	Value · USD	Signals	Src
Dare Bioscience, Inc.Listing on record	Jul 2, 2026	Award	38,862	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	Jun 15, 2026	AwardD (derivative)	87,900	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Dare Bioscience, Inc.Listing on record	Jun 11, 2026	AwardD (derivative)	10,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 29, 2026	AwardD (derivative)	2,567	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	ExerciseD (derivative)	-3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 21, 2026	Exercise	3,318	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	May 6, 2026	ExerciseD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
FATE THERAPEUTICS INCListing on record	May 6, 2026	Exercise	25,000	1.69 USD	$42.3K		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	ExerciseD (derivative)	-18,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	Exercise	18,000	47.89 USD	$862K	Unusual size	SEC
NEUROCRINE BIOSCIENCES INCListing on record	Nov 6, 2025	Sell	-18,000	151.82 USD	$2.7M	Unusual size	SEC
Dare Bioscience, Inc.Listing on record	Jul 10, 2025	AwardD (derivative)	4,500	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,650	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-2,325	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-60,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-30,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-9,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-15,000	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-44,264	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	Other	-57,292	—	n/a (No price was disclosed in the filing)		SEC
Regulus Therapeutics Inc.Listing unverified	Jun 27, 2025	OtherD (derivative)	-4,000	—	n/a (No price was disclosed in the filing)		SEC
FATE THERAPEUTICS INCListing on record	May 30, 2025	AwardD (derivative)	55,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	Exercise	2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC
NEUROCRINE BIOSCIENCES INCListing on record	May 22, 2025	ExerciseD (derivative)	-2,869	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))		SEC